The Drug Development Paradigm in Oncology Proceedings of a Workshop 1st Edition by And Medicine Engineering National Academies Of Sciences ISBN 9780309457958 0309457955

The Drug Development Paradigm in Oncology Proceedings of a Workshop 1st Edition by And Medicine Engineering National Academies Of Sciences – Ebook PDF Instant Download/Delivery: 9780309457958 ,0309457955
Full download The Drug Development Paradigm in Oncology Proceedings of a Workshop 1st Edition after payment

Product details:
ISBN 10: 0309457955
ISBN 13: 9780309457958
Author: And Medicine Engineering National Academies Of Sciences

Advances in cancer research have led to an improved understanding of the molecular mechanisms underpinning the development of cancer and how the immune system responds to cancer. This influx of research has led to an increasing number and variety of therapies in the drug development pipeline, including targeted therapies and associated biomarker tests that can select which patients are most likely to respond, and immunotherapies that harness the body’s immune system to destroy cancer cells. Compared with standard chemotherapies, these new cancer therapies may demonstrate evidence of benefit and clearer distinctions between efficacy and toxicity at an earlier stage of development. However, there is a concern that the traditional processes for cancer drug development, evaluation, and regulatory approval could impede or delay the use of these promising cancer treatments in clinical practice. This has led to a number of efforts—by patient advocates, the pharmaceutical industry, and the Food and Drug Administration (FDA)—to accelerate the review of promising new cancer therapies, especially for cancers that currently lack effective treatments. However, generating the necessary data to confirm safety and efficacy during expedited drug development programs can present a unique set of challenges and opportunities.

To explore this new landscape in cancer drug development, the National Academies of Sciences, Engineering, and Medicine developed a workshop held in December 2016. This workshop convened cancer researchers, patient advocates, and representatives from industry, academia, and government to discuss challenges with traditional approaches to drug development, opportunities to improve the efficiency of drug development, and strategies to enhance the information available about a cancer therapy throughout its life cycle in order to improve its use in clinical practice. This publication summarizes the presentations and discussions from the workshop.

The Drug Development Paradigm in Oncology Proceedings of a Workshop 1st Edition Table of contents:

1. Background on Drug Development and Regulatory Review

   • Types of FDA Drug Development and Approval Pathways

   • Ethical Requirements of Clinical Research

2. Exploring the Challenges with Traditional Clinical Drug Development

   • Inefficiencies and Long Development Timelines

   • Generalizability of Clinical Trial Results to Clinical Practice

   • Appropriate Use of Biomarkers and Surrogate Endpoints

   • Finding the Right Dose

3. New Strategies in Oncology Drug Development

   • Patient-Centered Drug Development

   • Informed Consent

   • Patient Risk

   • Mechanism-Informed Cancer Drug Development

     • Targeting Mutations in Breast Cancer

     • Targeting the Microenvironment in Multiple Myeloma

   • Functional Imaging

   • New Endpoints

4. Potential Policy Opportunities

5. Examples of Innovations in Cancer Drug Development

6. Workshop Wrap-Up

Appendices

• Appendix A: Statement of Task

• Appendix B: Workshop Agenda

People also search for The Drug Development Paradigm in Oncology Proceedings of a Workshop 1st Edition:

    
what is the difference between drug discovery and drug development
    
is drug development biotech
    
the drug progression theory
    
drug development
    
paradigm drug dealer

Tags: And Medicine Engineering National Academies Of Sciences, Drug Development Paradigm, Oncology